| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gregory E Simon, Rebecca C Rossom, Esti Iturralde, Brian K Ahmedani, Stephen C Waring, Ashli A Owen-Smith, Stacy A Sterling, Kathleen Miley, Cheryl D Stults, Yihe G Daida, Frances L Lynch, Arne Beck, Katherine Sanchez, Karen J Coleman, Susan M Shortree. Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine. The Journal of clinical psychiatry. vol 85. issue 2. 2024-05-02. PMID:38696137. |
clozapine use among people with psychotic disorders who experience specific indications for clozapine. |
2024-05-02 |
2024-05-04 |
Not clear |
| Andrea Mallorquí, Cristina Oliveira, Jose Rios, Maria Pilar Isla-Pera, Joaquin Gil-Badenes, Silvia Amoretti, Miguel Bernardo, Eduard Vieta, Eduard Parellada, Marina Garriga, Clemente García-Riz. Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. Archives of psychiatric nursing. vol 46. 2023-10-16. PMID:37813503. |
thirty-one outpatients from the outpatient clinical facility of hospital clinic in barcelona, spain diagnosed with schizophrenia and other psychotic disorders receiving clozapine treatment were enrolled in a prospective interventional study, comprising an 8-week group program of therapeutic education in a healthy lifestyle. |
2023-10-16 |
2023-11-08 |
Not clear |
| Eromona Whiskey, Graziella Romano, Matilda Elliott, Malcolm Campbell, Cholan Anandarajah, David Taylor, Koravangattu Valsra. Possible pharmacogenetic factors in clozapine treatment failure: a case report. Therapeutic advances in psychopharmacology. vol 11. 2022-02-25. PMID:35211290. |
this is critically important in the treatment of refractory psychotic disorders, where clozapine is the only evidence-based treatment but only about half the patients experience an adequate response. |
2022-02-25 |
2023-08-13 |
Not clear |
| Sujita Kumar Ka. Influence of haloperidol and clozapine on the cognitive performance in patients with psychotic disorders: Possible attributes. CNS spectrums. 2022-01-26. PMID:35078548. |
influence of haloperidol and clozapine on the cognitive performance in patients with psychotic disorders: possible attributes. |
2022-01-26 |
2023-08-13 |
Not clear |
| Felix-Martin Werner, Rafael Coveña. The Novel Antipsychotic Drug Cariprazine and Cognition Enhancing Drugs: Indications for their Use as the Add-on Therapy in Schizophrenia. Current pharmaceutical design. vol 27. issue 39. 2021-12-07. PMID:33302854. |
some patients show treatment-resistant forms of psychotic disorders, and in this case, they can be treated with clozapine. |
2021-12-07 |
2023-08-13 |
Not clear |
| Jessica W Y Yuen, Claire Wu, Cathy K Wang, David D Kim, Ric M Procyshyn, William G Panenka, William G Honer, Alasdair M Bar. A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance. Psychoneuroendocrinology. vol 129. 2021-10-11. PMID:34023734. |
clozapine is a second generation antipsychotic drug that has proven to be helpful in the management of patients with psychotic disorders that are resistant to other medications. |
2021-10-11 |
2023-08-13 |
rat |
| Robert O Cotes, A Umair Janjua, Beth Broussard, David Lazris, Ayesha Khan, Yunshen Jiao, Sarah L Kopelovich, David R Goldsmit. A Comparison of Attitudes, Comfort, and Knowledge of Clozapine Among Two Diverse Samples of US Psychiatrists. Community mental health journal. 2021-05-30. PMID:34052963. |
continuing professional education on clozapine are needed for psychiatrists who see individuals with psychotic disorders. |
2021-05-30 |
2023-08-13 |
Not clear |
| Miquel Bioque, Eduard Parellada, Clemente García-Rizo, Sílvia Amoretti, Adriana Fortea, Giovanni Oriolo, Pol Palau, Ester Boix-Quintana, Gemma Safont, Miquel Bernard. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study. European psychiatry : the journal of the Association of European Psychiatrists. vol 63. issue 1. 2021-04-13. PMID:32669145. |
clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: a retrospective 6-month mirror-image study. |
2021-04-13 |
2023-08-13 |
Not clear |
| Vishal Bhavsar, Kyriaki Kosidou, Linnea Widman, Nicola Orsini, John Hodsoll, Christina Dalman, James H MacCab. Clozapine Treatment and Offending: A Within-Subject Study of Patients With Psychotic Disorders in Sweden. Schizophrenia bulletin. vol 46. issue 2. 2021-02-08. PMID:31150553. |
clozapine treatment and offending: a within-subject study of patients with psychotic disorders in sweden. |
2021-02-08 |
2023-08-13 |
Not clear |
| Vishal Bhavsar, Kyriaki Kosidou, Linnea Widman, Nicola Orsini, John Hodsoll, Christina Dalman, James H MacCab. Clozapine Treatment and Offending: A Within-Subject Study of Patients With Psychotic Disorders in Sweden. Schizophrenia bulletin. vol 46. issue 2. 2021-02-08. PMID:31150553. |
clozapine treatment may have beneficial effects on behavioral outcomes in psychotic disorders, including violent offending. |
2021-02-08 |
2023-08-13 |
Not clear |
| Vishal Bhavsar, Kyriaki Kosidou, Linnea Widman, Nicola Orsini, John Hodsoll, Christina Dalman, James H MacCab. Clozapine Treatment and Offending: A Within-Subject Study of Patients With Psychotic Disorders in Sweden. Schizophrenia bulletin. vol 46. issue 2. 2021-02-08. PMID:31150553. |
in patients with psychotic disorders, clozapine treatment is associated with a lower rate of violent offending compared to olanzapine. |
2021-02-08 |
2023-08-13 |
Not clear |
| Sephora M Tang, Aylar Ansarian, Darren B Courtne. Clozapine Treatment and Cannabis Use in Adolescents with Psychotic Disorders - A Retrospective Cohort Chart Review. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent. vol 26. issue 1. 2020-10-01. PMID:28331504. |
clozapine treatment and cannabis use in adolescents with psychotic disorders - a retrospective cohort chart review. |
2020-10-01 |
2023-08-13 |
Not clear |
| Aslıhan Polat, Uğur Çakir, Nermin Gündü. Leukocytosis after Clozapine Treatment in a Patient with Chronic Schizophrenia. Noro psikiyatri arsivi. vol 53. issue 1. 2020-09-30. PMID:28360774. |
clozapine is an atypical antipsychotic drug that is approved by the us food and drug administration (fda) for the treatment of psychotic disorders. |
2020-09-30 |
2023-08-13 |
Not clear |
| Bryan K Sackey, Troy A Moore, Nicole L Cupples, Cynthia A Gutierre. Clozapine-induced myocarditis: Two case reports and review of clinical presentation and recognition. The mental health clinician. vol 8. issue 6. 2020-09-30. PMID:30397572. |
we report 2 cases of patients with primary psychotic disorders treated with clozapine, who developed signs and symptoms of myocarditis. |
2020-09-30 |
2023-08-13 |
Not clear |
| Nina H Grootendorst-van Mil, Anna R M Huiskens, Sieds Dieleman, Tom K Birkenhäge. Response after Infection-Associated Rise in Clozapine Levels in Treatment-Resistant Schizoaffective Disorder. Case reports in psychiatry. vol 2018. 2020-09-29. PMID:29623228. |
the report suggests a careful reevaluation of the clozapine dose in cases of treatment-resistant psychotic disorders with failed trials of clozapine. |
2020-09-29 |
2023-08-13 |
Not clear |
| Eromona Whiskey, Shirley Yuen, Emma Khosla, Susan Piper, David O'Flynn, David Taylo. Resolution without discontinuation: heart failure during clozapine treatment. Therapeutic advances in psychopharmacology. vol 10. 2020-09-28. PMID:32547730. |
unfortunately, clozapine is frequently discontinued due to both real and perceived serious, and potentially life-threatening, adverse effects, contributing to the underutilisation of the most effective treatment in refractory psychotic disorders. |
2020-09-28 |
2023-08-13 |
Not clear |
| Dongbin Lee, Ji Hyun Baek, Moonoh Bae, Yujin Choi, Kyung Sue Hon. Long-Term Response to Clozapine and Its Clinical Correlates in the Treatment of Tardive Movement Syndromes: A Naturalistic Observational Study in Patients With Psychotic Disorders. Journal of clinical psychopharmacology. vol 39. issue 6. 2020-04-20. PMID:31688397. |
long-term response to clozapine and its clinical correlates in the treatment of tardive movement syndromes: a naturalistic observational study in patients with psychotic disorders. |
2020-04-20 |
2023-08-13 |
Not clear |
| Robert L Smith, Lennart Kyllesø, Tore Haslemo, Ole Andreas Andreassen, Espen Molde. Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism. Therapeutic drug monitoring. vol 41. issue 4. 2020-03-10. PMID:31259880. |
valproic acid (vpa) is frequently used together with clozapine (clz) as mood-stabilizer or for the prevention of seizures in patients with psychotic disorders. |
2020-03-10 |
2023-08-13 |
Not clear |
| Kristen Thien, Brian O'Donoghu. Delays and barriers to the commencement of clozapine in eligible people with a psychotic disorder: A literature review. Early intervention in psychiatry. vol 13. issue 1. 2019-07-19. PMID:29984888. |
delays and barriers to the commencement of clozapine in eligible people with a psychotic disorder: a literature review. |
2019-07-19 |
2023-08-13 |
Not clear |
| Alexander Morris Kaplan, William Bradly Pitts, Iqbal Ahme. An Unexpected Circumstance: Acute Dystonic Reaction in the Setting of Clozapine Administration. Journal of pharmacy practice. vol 32. issue 1. 2019-03-20. PMID:29092658. |
clozapine is a second-generation antipsychotic typically reserved for refractory psychotic disorders due to its high-risk side effect profile to include agranulocytosis, with its attendant need for regular blood draws. |
2019-03-20 |
2023-08-13 |
Not clear |